BioCentury
ARTICLE | Top Story

Immunex meets Street EPS

October 17, 2001 7:00 AM UTC

IMNX reported third quarter EPS of $0.07 after market close, meeting the consensus Street estimate. Revenues for the quarter were $253 million, up from $219 million for the third quarter in 2000. Sale...